Xeris Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14M | 1.7M | 8.14 |
| 2025-06-30 | $5.7M | 1.2M | 4.67 |
| 2025-03-31 | $3.2M | 590k | 5.49 |
| 2024-12-31 | $581k | 171k | 3.39 |
| 2024-09-30 | $237k | 83k | 2.85 |
| 2022-03-31 | $74k | 29k | 2.56 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management